Please assess the completion status of the following clinical trial:

Trial Title: Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~At time of diagnosis~* De novo multiple myeloma patients under 65 or in first relapse, in whom screening for chromosome 13 deletion and beta2microglobulin assay have been performed.~* Salmon and Durie Stage: III, II, I with symptomatic bone lesion (radiological)~* Patient's written informed consent~* No clinical signs of heart failure or coronary insufficiency with LVEF\>50%~* No hepatic in insufficiency: bilirubin\<35μmol/l and SGOT, SGPT, alkaline phosphatase less than 2.5 N~* No respiratory insufficiency: normal pulmonary function tests and DLCO\>50%~* No pre-existing renal impairment not related to the disease~* No history of any other malignant disease with the exception of basal cell carcinoma and stage I cervical cancer~* Negative HIV serology~* Effective contraception when justified~At the time of transplantation~* Good performance status (WHO score≤2)~* Creatinine≤170μmol/l and no ineligibility criteria for intensification~* Stem cells harvest ≥ 5x10E6 CD34/kg for 2 ASCT~* Absence of progressive disease before transplantation~Exclusion Criteria:~* Known refusal of the subject to participate to the study~* Female subject who is pregnant or breast-feeding~* History of allergy to any of the study medications, their analogues, or excipients in the various formulations~* Main liver insufficiency~* ≥ Grade 3 peripheral neuropathy on clinical examination within 14 days before enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): bortézomib

Based on this trial design, predict the completion outcome and termination type (if applicable).